Intracorporeal versus extracorporeal anastomosis for robotic ileocolic resection in Crohn's disease

To date, there is no cohort in the literature focusing on the impact of the type of anastomosis in robotic ileocolonic resections for Crohn's Disease (CD). We aimed to compare short-term postoperative outcomes of robotic ileocolic resection for CD between patients who had intracorporeal (ICA) or extracorporeal anastomosis (ECA). We retrospectively included all consecutive robotic ileocolonic resections for CD at our institution between 2014 and 2020. We compared baseline, perioperative characteristics, and postoperative outcomes between ICA and ECA. The analysis included 89 patients: 71% underwent ICA and 29% ECA. Groups were similar in age, sex, body mass index, smoking, CD duration, Montreal classification, surgical history, and previous CD medical treatments. Return to bowel function was achieved sooner in the ICA group (ICA 1.6 +/- 0.7 day, ECA 2.1 +/- 0.8 days; p = 0.026) despite longer operative time (ICA 235 +/- 79 min, ECA 172 +/- 51 min; p < 0.001), but no statistical difference was found regarding ileus rate and length of stay. Overall, 30-day postoperative complication rate was 23.6% (ICA 22.2%, ECA 26.9%; p = 0.635). There were no abdominal septic complications, anastomotic leaks, or severe postoperative complications. In conclusion, robotic ileocolic resection for CD shows acceptable 30 days outcomes for both ICA and ECA. ICA was associated with a faster return to bowel function without impact on the length of stay or 30-day complications. Further studies are needed to confirm the benefits of ICA in the setting of ileocolic resections for CD.

Automated summary

This retrospective study compared the short-term postoperative outcomes of intracorporeal versus extracorporeal anastomosis in robotic ileocolic resections for Crohn's Disease. The results showed that patients with intracorporeal anastomosis had a faster return to bowel function, despite longer operative time, with no significant differences in complication rates and length of stay between the two groups. Further studies are needed to confirm the benefits of intracorporeal anastomosis in ileocolic resections for Crohn's Disease.